Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
Summary Coming Soon
Our AI is still processing this episode. Summaries typically appear within 24-48 hours of episode release.
Want to be notified when this summary is ready? Subscribe to get weekly digests with AI summaries of all new episodes.
You just read a 3-minute summary of a 22-minute episode.
Get BioCentury This Week summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from BioCentury This Week
Ep. 371 - Moving faster at the academia-industry interface
Jun 11 · 32 min
Investing for Beginners
AAR54 - AI and Your Finances: Tool or Risk
Jun 16
More from BioCentury This Week
Ep. 370 - Calmer waters for FDA; Servier, Lilly deals
Jun 9 · 34 min
Citeline Podcasts
Philips' Shez Partovi on increasing AI adoption, clinicians' attitudes and the hybrid care model
Jun 16
More from BioCentury This Week
We summarize every new episode. Want them in your inbox?
Ep. 371 - Moving faster at the academia-industry interface
Ep. 370 - Calmer waters for FDA; Servier, Lilly deals
Ep. 369 - ASCO advances, China innovation & U.S. science under threat
Ep. 368 - ASCO Preview, China Policy, ADC Linkers
Ep. 367 - FDA, obesity targets and the rise of DACs
Similar Episodes
Related episodes from other podcasts
Investing for Beginners
Jun 16
AAR54 - AI and Your Finances: Tool or Risk
Citeline Podcasts
Jun 16
Philips' Shez Partovi on increasing AI adoption, clinicians' attitudes and the hybrid care model
This Week in Startups
Jun 15
The Startup Building the First Hotel on the Moon…
Marketing School
Jun 15
Your Brain Hasn't Changed in 190,000 Years
a16z Podcast
Jun 15
AI, Design, and the Power of Open Models
This podcast is featured in Best Biotech Podcasts (2026) — ranked and reviewed with AI summaries.
You're clearly into BioCentury This Week.
Every Monday, we deliver AI summaries of the latest episodes from BioCentury This Week and 192+ other podcasts. Free for up to 3 shows.
Start My Monday DigestNo credit card · Unsubscribe anytime